BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30033308)

  • 1. Synthesis and characterization of MCM-48/hydroxyapatite composites for drug delivery: Ibuprofen incorporation, location and release studies.
    Pajchel L; Kolodziejski W
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():734-742. PubMed ID: 30033308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid State NMR Characterization of Ibuprofen:Nicotinamide Cocrystals and New Idea for Controlling Release of Drugs Embedded into Mesoporous Silica Particles.
    Skorupska E; Kaźmierski S; Potrzebowski MJ
    Mol Pharm; 2017 May; 14(5):1800-1810. PubMed ID: 28403609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double barrier as an effective method for slower delivery rate of ibuprofen.
    Kurczewska J; Lewandowski D; Olejnik A; Schroeder G; Nowak I
    Int J Pharm; 2014 Sep; 472(1-2):248-50. PubMed ID: 24968140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
    Yang P; Quan Z; Lu L; Huang S; Lin J
    Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of heparin on enlarged-pore and functionalized MCM-41.
    Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A; Souza KC; Sousa EM
    Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphene oxide and creatine phosphate disodium dual template-directed synthesis of GO/hydroxyapatite and its application in drug delivery.
    Yao C; Zhu J; Xie A; Shen Y; Li H; Zheng B; Wei Y
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():709-715. PubMed ID: 28183664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional materials such as MCM-41÷Fe3O4÷folic acid as drug delivery system.
    Popescu S; Ardelean IL; Gudovan D; Rădulescu M; Ficai D; Ficai A; Vasile BŞ; Andronescu E
    Rom J Morphol Embryol; 2016; 57(2):483-9. PubMed ID: 27516022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs.
    Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembly of nanohydroxyapatite in mesoporous silica.
    Shi X; Wang Y; Wei K; Ren L; Lai C
    J Mater Sci Mater Med; 2008 Aug; 19(8):2933-40. PubMed ID: 18360795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug.
    Zhai QZ
    J Microencapsul; 2013; 30(2):173-80. PubMed ID: 22894165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
    Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
    Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
    Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
    J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective controlled release of captopril by silylation of mesoporous MCM-41.
    Qu F; Zhu G; Huang S; Li S; Qiu S
    Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen.
    Xin W; Wang Y; Guo X; Gou K; Li J; Li S; Zhao L; Li H
    Int J Nanomedicine; 2020; 15():7451-7468. PubMed ID: 33116481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug release profiles of modified MCM-41 with superparamagnetic behavior correlated with the employed synthesis method.
    Cuello NI; Elías VR; Mendieta SN; Longhi M; Crivello ME; Oliva MI; Eimer GA
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():674-681. PubMed ID: 28576037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the role of integrated carbohydrate polymers (starch, chitosan, and β-cyclodextrin) with mesoporous silica as carriers for ibuprofen drug; equilibrium and pharmacokinetic properties.
    Abukhadra MR; Refay NM; Nadeem A; El-Sherbeeny AM; Ibrahim KE
    Int J Biol Macromol; 2020 Aug; 156():537-547. PubMed ID: 32294500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.